Zobrazeno 1 - 10 of 10 pro vyhledávání: '"Alexandre, Kaoukhov"'
3
Efficacy and Safety of Sarecycline, a Novel, Once-Daily, Narrow Spectrum Antibiotic for the Treatment of Moderate to Severe Facial Acne Vulgaris: Results of a Phase 2, Dose-Ranging Study
Autor: James J, Leyden, Vilma, Sniukiene, David R, Berk, Alexandre, Kaoukhov
Publikováno v: Journal of drugs in dermatology : JDD. 17(3)
There is a need for new oral antibiotics for acne with improved safety profiles and targeted antibacterial spectra. Sarecycline is a novel, tetracycline-class antibiotic specifically designed for acne, offering a narrow spectrum of activity compared
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::0eaa5b3d53f4d142a34ed765202ac85b
https://pubmed.ncbi.nlm.nih.gov/29537451
Zobrazit plný text záznamu
4
Treatment Response With Once-Daily Topical Dapsone Gel, 7.5% for Acne Vulgaris: Subgroup Analysis of Pooled Data from Two Randomized, Double-Blind Stu
Autor: Zoe Diana, Draelos, David A, Rodriguez, Steven E, Kempers, Suzanne, Bruce, Marina I, Peredo, Jeanine, Downie, Joan-En, Chang-Lin, David R, Berk, Shiling, Ruan, Alexandre, Kaoukhov
Publikováno v: Journal of drugs in dermatology : JDD. 16(6)
pBACKGROUND: Acne vulgaris has varying physical and psychological effects in men and women of different ages, races, and ethnicities./ppOBJECTIVE: This analysis assessed the relationship of age, sex, and race to treatment response with once-daily top
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::5469ebf879703fcee7d75bb3a663d233
https://pubmed.ncbi.nlm.nih.gov/28686777
Zobrazit plný text záznamu
5
Safety and Pharmacokinetics of Once-Daily Dapsone Gel, 7.5% in Patients With Moderate Acne Vulgaris
Autor: Michael T, Jarratt, Terry M, Jones, Joan-En, Chang-Lin, Warren, Tong, David R, Berk, Vince, Lin, Alexandre, Kaoukhov
Publikováno v: Journal of drugs in dermatology : JDD. 15(10)
Reducing the dosing frequency of topical acne treatments to once daily may improve adherence.Evaluate pharmacokinetics (PK), safety, and tolerability of 3 formulations of once-daily dapsone gel, 7.5% and of twice-daily dapsone gel, 5% over 28 days in
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b8e8ce52a8a2522a9727badb0697f22b
https://pubmed.ncbi.nlm.nih.gov/27741344
Zobrazit plný text záznamu
6
Efficacy and Safety of Once-Daily Dapsone Gel, 7.5% for Treatment of Adolescents and Adults With Acne Vulgaris: Second of Two Identically Designed, Large, Multicenter, Randomized, Vehicle-Controlled Trials
Autor: Lawrence F, Eichenfield, Ted, Lain, Ellen H, Frankel, Terry M, Jones, Joan-En, Chang-Lin, David R, Berk, Shiling, Ruan, Alexandre, Kaoukhov
Publikováno v: Journal of drugs in dermatology : JDD. 15(8)
Dapsone gel, 5% is administered twice daily for the treatment of acne vulgaris, and some patients may find adherence challenging.BR /The study objective was to assess the efficacy and safety, compared with vehicle, of acne treatment with a recently F
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::91717abad9d7df342badbd76a8cdd7ba
https://pubmed.ncbi.nlm.nih.gov/27537997
Zobrazit plný text záznamu
7
Efficacy and Safety of Once-Daily Dapsone Gel, 7.5% for Treatment of Adolescents and Adults With Acne Vulgaris: First of Two Identically Designed, Large, Multicenter, Randomized, Vehicle-controlled Trials
Autor: Linda F, Stein Gold, Michael T, Jarratt, Alicia D, Bucko, Steven K, Grekin, Joshua M, Berlin, Michael, Bukhalo, Jonathan S, Weiss, David R, Berk, Joan-En, Chang-Lin, Vince, Lin, Alexandre, Kaoukhov
Publikováno v: Journal of drugs in dermatology : JDD. 15(5)
Treatment of acne vulgaris (acne) with dapsone gel, 5% requires twice-daily dosing, and some patients may not adhere to this regimen.br /The objective of this study was to assess the efficacy and safety of a new, once-daily formulation of dapsone gel
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::5ca40dc9760f47294f275b17602aa6f4
https://pubmed.ncbi.nlm.nih.gov/27168264
Zobrazit plný text záznamu
9
Adapalene gel 0.1% is better tolerated than tretinoin gel 0.025% among healthy volunteers of various ethnic origins
Autor: Pascale Soto, Chee-Leok Goh, Mark B Y Tang, Philippe Briantais, Alexandre Kaoukhov
Publikováno v: The Journal of dermatological treatment. 20(5)
The efficacious acne treatment adapalene gel 0.1% is significantly less irritating than tretinoin of various concentrations and formulations, according to several clinical studies conducted predominantly in Caucasian patients.To confirm the lower irr
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8dfb8dc7ffcea8f1370a100f00808342
https://pubmed.ncbi.nlm.nih.gov/19634042
Zobrazit plný text záznamu
10
FS03.5 Evaluation of the irritancy potential of adapalene and tretinoin in volunteers of different ethnic origins
Autor: Pascale Soto, Chee-Leok Goh, V Sorba, A T-J Goon, Alexandre Kaoukhov
Publikováno v: Contact Dermatitis. 50:135-135
Objectives: To compare the cumulative irritancy potential of adapalene gel, 0.1% to that of tretinoin gel, 0.025% following repeated applications to the skin of human volunteers of different ethnic origins. Methods: Single center study, randomized, i
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7ebd49fa97203ec0228a8045e1312429
https://doi.org/10.1111/j.0105-1873.2004.0309ag.x
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje